Insider Shareholders with Direct Ownership of Salarius Pharmaceuticals, Inc. (SLRX)
This section provides a comprehensive overview of the insiders with direct ownership of Salarius Pharmaceuticals, Inc. (SLRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Salarius Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David J. Arthur
Chief Executive Officer |
238,428 | 0 | 48,019 $67,226 | 9 |
Feb 13, 2023
Added 22.95%
|
|
Mark J Rosenblum
Exec VP Finance, CFO |
158,065 | 0 | 21,851 $30,591 | 9 |
Feb 13, 2023
Added 22.74%
|
|
Jonathan I Lieber
Director |
38,940 | 0 | 2,940 $4,116 | 2 |
Jan 03, 2023
Added 32.88%
|
|
Tess Burleson
Director |
29,140 | 0 | 2,722 $3,810 | 2 |
Jan 03, 2023
Added 34.6%
|
|
William K. Mc Vicar
Director |
1,440 | 0 | 1,788 $2,503 | 1 |
Jan 03, 2023
Added 44.61%
|
|
Bruce J Mc Creedy Jr.
Director |
1,440 | 0 | 1,788 $2,503 | 1 |
Jan 03, 2023
Added 44.61%
|
|
Paul Lammers
Director |
1,440 | 0 | 1,718 $2,405 | 1 |
Jan 03, 2023
Added 45.6%
|
|
Arnold C Hanish
Director |
1,440 | 0 | 1,440 $2,015 | 1 |
Jan 03, 2023
Added 50.0%
|